<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="39832">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02587858</url>
  </required_header>
  <id_info>
    <org_study_id>10832</org_study_id>
    <nct_id>NCT02587858</nct_id>
  </id_info>
  <brief_title>NBIAready: Online Collection of Natural History Patient-reported Outcome Measures</brief_title>
  <official_title>NBIAready: Online Collection of Natural History Patient-reported Outcome Measures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Susan J. Hayflick</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn more about a subtype of Neurodegeneration with Brain
      Iron Accumulation (NBIA) called Pantothenate Kinase-Associated Neurodegeneration (PKAN) by
      (1) collecting information about how symptoms and findings in NBIA change over time and (2)
      identifying measures of NBIA that can be used in future clinical trials. Participants will
      logon to a secure website from home every 6 months for a period of 5 years to electronically
      complete a set of rating scales as related to their NBIA.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">April 2025</completion_date>
  <primary_completion_date type="Anticipated">April 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>Document the natural history of NBIA and identify new markers of disease progression.</measure>
    <time_frame>5 years</time_frame>
    <description>The unit of analyses will be the data collected on NBIA milestones and patient-reported outcome measures. Descriptive statistics will be used to characterize the natural history of NBIA. If data support that certain disease milestones occur in a consistent order, or at consistent ages, then these data points will be candidate markers of disease progression. Descriptive statistics will be used to characterize the natural history of NBIA and identify areas in which individuals with NBIA differ from the general population.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Neurodegeneration With Brain Iron Accumulation (NBIA)</condition>
  <arm_group>
    <arm_group_label>PKAN</arm_group_label>
    <description>This group consists of individuals diagnosed with PKAN using a combination of MRI and PANK2 gene sequencing.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The PKAN group consists of international individuals diagnosed with PKAN.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of PKAN confirmed by MRI and gene testing.

          -  Ability to access a computer with internet services approximately once every 6 months
             for up to 5 years to enter data.

        Exclusion Criteria:

          -  Individuals who are not fluent in reading English.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan J Hayflick, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leila K Schwanemann</last_name>
    <phone>503 494 6838</phone>
    <email>schwanem@ohsu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Allison M Gregory, MS, CGC</last_name>
    <phone>503 494 4344</phone>
    <email>gregorya@ohsu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239-3098</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leila K Schwanemann</last_name>
      <phone>503-494-6838</phone>
      <email>schwanem@ohsu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Allison M Gregory, MS, CGC</last_name>
      <phone>503 494 4344</phone>
      <email>gregorya@ohsu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Susan J Hayflick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.nbiacure.org</url>
  </link>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 27, 2016</lastchanged_date>
  <firstreceived_date>October 23, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health &amp; Science University</investigator_affiliation>
    <investigator_full_name>Susan J. Hayflick</investigator_full_name>
    <investigator_title>Professor &amp; Chair, Molecular &amp; Medical Genetics</investigator_title>
  </responsible_party>
  <keyword>NBIA</keyword>
  <keyword>PKAN</keyword>
  <keyword>brain iron</keyword>
  <keyword>Neurodegeneration with Brain Iron Accumulation</keyword>
  <keyword>Hallervorden Spatz Syndrome</keyword>
  <keyword>Pantothenate Kinase Associated Neurodegeneration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nerve Degeneration</mesh_term>
    <mesh_term>Pantothenate Kinase-Associated Neurodegeneration</mesh_term>
    <mesh_term>Neuroaxonal Dystrophies</mesh_term>
    <mesh_term>Iron Metabolism Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
